DK157482A - GALENIC PREPARATION CONTAINING GALLOPAMIL OR VERAPAMIL AND PROCEDURES FOR PREPARING IT - Google Patents

GALENIC PREPARATION CONTAINING GALLOPAMIL OR VERAPAMIL AND PROCEDURES FOR PREPARING IT Download PDF

Info

Publication number
DK157482A
DK157482A DK157482A DK157482A DK157482A DK 157482 A DK157482 A DK 157482A DK 157482 A DK157482 A DK 157482A DK 157482 A DK157482 A DK 157482A DK 157482 A DK157482 A DK 157482A
Authority
DK
Denmark
Prior art keywords
active compound
gallopamil
verapamil
procedures
preparing
Prior art date
Application number
DK157482A
Other languages
Danish (da)
Inventor
H Einig
V Buehler
W Koch
J A Schwarz
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6129505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK157482(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Basf Ag filed Critical Basf Ag
Publication of DK157482A publication Critical patent/DK157482A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1. A pharmaceutical composition which contains a calcium-antagonistic active compound, with or without additional active compounds, is intended for oral administration to produce a sustained action for continuous therapy and contains only the sustaining dose of active compound, bound to pharmaceutical auxiliaries, wherein the calcium-antagonistic active compound is Gallopamil or Verapamil and wherein, at the sustaining dose, the ratio of the constituents with rapid release of active compound to those with sustained release of active compound is from 1 : 0.6 to 1 : 6.
DK157482A 1981-04-07 1982-04-06 GALENIC PREPARATION CONTAINING GALLOPAMIL OR VERAPAMIL AND PROCEDURES FOR PREPARING IT DK157482A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813113901 DE3113901A1 (en) 1981-04-07 1981-04-07 ACTIVE SUBSTANCE PREPARATION FOR ORAL APPLICATION

Publications (1)

Publication Number Publication Date
DK157482A true DK157482A (en) 1982-10-08

Family

ID=6129505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK157482A DK157482A (en) 1981-04-07 1982-04-06 GALENIC PREPARATION CONTAINING GALLOPAMIL OR VERAPAMIL AND PROCEDURES FOR PREPARING IT

Country Status (17)

Country Link
EP (1) EP0063266B1 (en)
JP (1) JPS57175113A (en)
AT (1) ATE14076T1 (en)
AU (1) AU555093B2 (en)
CA (1) CA1184497A (en)
DE (2) DE3113901A1 (en)
DK (1) DK157482A (en)
ES (1) ES8307496A1 (en)
FI (1) FI821253L (en)
GR (1) GR74770B (en)
HU (1) HU186855B (en)
IE (1) IE52985B1 (en)
IL (1) IL65328A (en)
NO (1) NO157204C (en)
NZ (1) NZ200244A (en)
PT (1) PT74705B (en)
ZA (1) ZA822327B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
LU86077A1 (en) * 1985-09-18 1987-04-02 Pharlyse Sa NEW GALENIC FORMS OF VERAPAMIL, THEIR MANUFACTURE AND THE MEDICINAL PRODUCTS CONTAINING THESE NEW GALENIC FORMS
LU86099A1 (en) * 1985-09-30 1987-04-02 Pharlyse EXTENDED RELEASE GALENIC FORMS OF VERAPAMIL, THEIR MANUFACTURE AND THE MEDICINAL PRODUCTS CONTAINING THEM
IE58401B1 (en) * 1986-06-20 1993-09-08 Elan Corp Plc Controlled absorption pharmaceutical composition
US4981871A (en) * 1987-05-15 1991-01-01 Abelson Mark B Treatment of ocular hypertension with class I calcium channel blocking agents
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
DE3809764A1 (en) * 1988-03-23 1989-10-05 Knoll Ag MIXTURE OF ALGINATES AND POLYACRYLATES AND THEIR USE
US5230901A (en) * 1988-03-23 1993-07-27 Knoll Ag Sustained release tablet of a mixture of alginates and polyacrylates
ES2045281T3 (en) * 1988-07-13 1994-01-16 Knoll Ag MEDICATION FORM OF DELAYED ACTION ON THE BASIS OF ALGINATES.
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
DE3932378A1 (en) * 1989-09-28 1991-04-11 Knoll Ag SOLID MEDICAL FORM WITH A HIGH VERAPAMIL CONTENT
IT1264696B1 (en) * 1993-07-09 1996-10-04 Applied Pharma Res PHARMACEUTICAL FORMS INTENDED FOR ORAL ADMINISTRATION ABLE TO RELEASE ACTIVE SUBSTANCES AT A CONTROLLED AND DIFFERENTIATED SPEED
US6083532A (en) * 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154810B (en) * 1961-04-01 1963-09-26 Knoll Ag Process for the preparation of basic substituted phenylacetonitriles
DE1467781A1 (en) * 1963-07-15 1968-12-05 Boehringer Sohn Ingelheim Process for the production of coated tablets with extended release of active ingredients

Also Published As

Publication number Publication date
DE3113901A1 (en) 1982-10-28
AU8238482A (en) 1982-10-14
PT74705B (en) 1983-11-14
NZ200244A (en) 1984-08-24
EP0063266B1 (en) 1985-07-03
CA1184497A (en) 1985-03-26
EP0063266A2 (en) 1982-10-27
IL65328A0 (en) 1982-05-31
IE820812L (en) 1982-10-07
NO821084L (en) 1982-10-08
FI821253L (en) 1982-10-08
DE3264519D1 (en) 1985-08-08
ES511208A0 (en) 1983-08-16
AU555093B2 (en) 1986-09-11
GR74770B (en) 1984-07-12
IE52985B1 (en) 1988-04-27
FI821253A0 (en) 1982-04-07
ES8307496A1 (en) 1983-08-16
EP0063266A3 (en) 1983-05-04
IL65328A (en) 1985-06-30
ZA822327B (en) 1983-03-30
ATE14076T1 (en) 1985-07-15
JPS57175113A (en) 1982-10-28
NO157204B (en) 1987-11-02
HU186855B (en) 1985-10-28
PT74705A (en) 1982-05-01
NO157204C (en) 1988-02-10

Similar Documents

Publication Publication Date Title
DK157482A (en) GALENIC PREPARATION CONTAINING GALLOPAMIL OR VERAPAMIL AND PROCEDURES FOR PREPARING IT
NO171365C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZIMIDAZOLD DERIVATIVES
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE59102210D1 (en) Pharmaceutical formulation containing galanthemin for the treatment of alcoholism.
GR930100197A (en) Novel simethicone containing pharmaceutical compositions.
ES2171469T3 (en) COMPOSITION ADMINISTERED BY NASAL AND PREPARATION THAT CONTAINS IT.
ATE16191T1 (en) STABLE SALTS OF S-ADENOSINYLMETHIONINE, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES AS THE ACTIVE SUBSTANCE.
ATE220321T1 (en) ORAL DOSAGE FORMS CONTAINING SOLID FLUPIRTINE WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
KR830002510A (en) Composition consisting of biologically active compound and hydroxyalkyl starch
HK134494A (en) Substituted release azelastine containing medicaments
SE8600658D0 (en) NOVEL COMPOSITION OF MATTER
KR890004705A (en) Antiviral agents
ATE13488T1 (en) GALLIUM CHLORIDE, A NEW ANTI-CANCER AGENT.
KR880004810A (en) Peptic Ulcer Treatment
PH25715A (en) Cyclic growth hormone releasing factor analogs, pharmaceutical composition containing said compound , process for the preparation thereof
KR870001144A (en) Pharmaceutical composition containing NN-dimethylethyl oxide and its production method
KR910018026A (en) Drugs for treating urination disorders containing α-phenyl-αpyridylalkanoic acid derivatives
KR890007737A (en) Anti-caking agents
IL87867A0 (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-pyridine derivatives
KR890002058A (en) 2,4,6-tris-3-tert-butylamino-1, -3, -5-triazine for the prevention and treatment of epilepsy and anxiety
FR2567755B1 (en) NEW ANTI-TUMOR DRUG CONTAINING TRIACETOXY-1,8,9 ANTHRACENE AS ACTIVE INGREDIENT
TH3319EX (en) Methods for preparation N- (2-Pyrityl) -2-methyl-4-hydroxy-2H-1,2-benzothiazin-3-carboxamide -1,1 an Oxide
TH6256EX (en) Ariel derivatives, anti-inflammatory substances

Legal Events

Date Code Title Description
PBP Patent lapsed
AHS Application shelved for other reasons than non-payment